Knowledge somebody else already did the reading for.

One dated edition a week of what actually happened on ClinicalTrials.gov: trials newly registered, trials halted, trials completed, and the FDA approvals that landed alongside them. Every halt carries the sponsor's own stated reason, classified — because a registry status cannot tell a drug that failed from one that worked so well the trial stopped early, and it cannot tell either from a study paused for the summer. Reasons the sponsor did not give are marked as not given, never guessed.

One dated edition per month: every industry-sponsored Phase 2 and Phase 3 trial whose primary completion falls in the next two months, grouped by phase and graded for how much the date is worth believing. Every forward-looking completion date in the registry is the sponsor's estimate, so the grade — built from whether enrolment has closed, how far the trial has got, whether the sponsor named a day or only a month, and when the record was last revised — is the product. Withdrawn and suspended trials are kept off the calendar and listed separately. No PDUFA dates, no tickers, no probability of success: the registry publishes none of those.